Global Oligonucleotide Synthesis Market Research Report 2022

Market Analysis and Insights: Global Oligonucleotide Synthesis Market

Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.

The global Oligonucleotide Synthesis market size is projected to reach US$ 2946.1 million by 2028, from US$ 1856.3 million in 2021, at a CAGR of 6.4% during 2022-2028.

Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oligonucleotide Synthesis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oligonucleotide Synthesis market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oligonucleotide Synthesis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oligonucleotide Synthesis market.

Global Oligonucleotide Synthesis Scope and Market Size

Oligonucleotide Synthesis market is segmented by players, region (country), by Type and by End User. Players, stakeholders, and other participants in the global Oligonucleotide Synthesis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End User for the period 2017-2028.

Custom Oligonucleotides

Pre-designed Oligonucleotides

Academic Research Institutes

Pharmaceutical and Biotechnology Companies

Diagnostic Laboratories

Others

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Integrated DNA Technologies

Merck

Eurofins Genomics

Thermo Fisher Scientific

Agilent Technologies

Eurogentec

GE Healthcare

LGC Biosearch Technologies

Nitto Denko Avecia

Genscript

Genedesign

TriLink Biotechnologies

Bio-Synthesis

ATDBio

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Custom Oligonucleotides

1.2.3 Pre-designed Oligonucleotides

1.3 Market by End User

1.3.1 Global Oligonucleotide Synthesis Market Share by End User: 2017 VS 2021 VS 2028

1.3.2 Academic Research Institutes

1.3.3 Pharmaceutical and Biotechnology Companies

1.3.4 Diagnostic Laboratories

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Oligonucleotide Synthesis Market Perspective (2017-2028)

2.2 Oligonucleotide Synthesis Growth Trends by Region

2.2.1 Oligonucleotide Synthesis Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Oligonucleotide Synthesis Historic Market Size by Region (2017-2022)

2.2.3 Oligonucleotide Synthesis Forecasted Market Size by Region (2023-2028)

2.3 Oligonucleotide Synthesis Market Dynamics

2.3.1 Oligonucleotide Synthesis Industry Trends

2.3.2 Oligonucleotide Synthesis Market Drivers

2.3.3 Oligonucleotide Synthesis Market Challenges

2.3.4 Oligonucleotide Synthesis Market Restraints

3.1 Global Top Oligonucleotide Synthesis Players by Revenue

3.1.1 Global Top Oligonucleotide Synthesis Players by Revenue (2017-2022)

3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Players (2017-2022)

3.2 Global Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Oligonucleotide Synthesis Revenue

3.4 Global Oligonucleotide Synthesis Market Concentration Ratio

3.4.1 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis Revenue in 2021

3.5 Oligonucleotide Synthesis Key Players Head office and Area Served

3.6 Key Players Oligonucleotide Synthesis Product Solution and Service

3.7 Date of Enter into Oligonucleotide Synthesis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2017-2022)

4.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2023-2028)

5.1 Global Oligonucleotide Synthesis Historic Market Size by End User (2017-2022)

5.2 Global Oligonucleotide Synthesis Forecasted Market Size by End User (2023-2028)

6.1 North America Oligonucleotide Synthesis Market Size (2017-2028)

6.2 North America Oligonucleotide Synthesis Market Size by Country (2017-2022)

6.3 North America Oligonucleotide Synthesis Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7.1 Europe Oligonucleotide Synthesis Market Size (2017-2028)

7.2 Europe Oligonucleotide Synthesis Market Size by Country (2017-2022)

7.3 Europe Oligonucleotide Synthesis Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8.1 Asia-Pacific Oligonucleotide Synthesis Market Size (2017-2028)

8.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Country (2017-2022)

8.3 Asia-Pacific Oligonucleotide Synthesis Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9.1 Latin America Oligonucleotide Synthesis Market Size (2017-2028)

9.2 Latin America Oligonucleotide Synthesis Market Size by Country (2017-2022)

9.3 Latin America Oligonucleotide Synthesis Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10.1 Middle East & Africa Oligonucleotide Synthesis Market Size (2017-2028)

10.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2017-2022)

10.3 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11.1 Integrated DNA Technologies

11.1.1 Integrated DNA Technologies Company Detail

11.1.2 Integrated DNA Technologies Business Overview

11.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Introduction

11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.1.5 Integrated DNA Technologies Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Oligonucleotide Synthesis Introduction

11.2.4 Merck Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.2.5 Merck Recent Development

11.3 Eurofins Genomics

11.3.1 Eurofins Genomics Company Detail

11.3.2 Eurofins Genomics Business Overview

11.3.3 Eurofins Genomics Oligonucleotide Synthesis Introduction

11.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.3.5 Eurofins Genomics Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Introduction

11.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Agilent Technologies

11.5.1 Agilent Technologies Company Detail

11.5.2 Agilent Technologies Business Overview

11.5.3 Agilent Technologies Oligonucleotide Synthesis Introduction

11.5.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.5.5 Agilent Technologies Recent Development

11.6 Eurogentec

11.6.1 Eurogentec Company Detail

11.6.2 Eurogentec Business Overview

11.6.3 Eurogentec Oligonucleotide Synthesis Introduction

11.6.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.6.5 Eurogentec Recent Development

11.7 GE Healthcare

11.7.1 GE Healthcare Company Detail

11.7.2 GE Healthcare Business Overview

11.7.3 GE Healthcare Oligonucleotide Synthesis Introduction

11.7.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.7.5 GE Healthcare Recent Development

11.8 LGC Biosearch Technologies

11.8.1 LGC Biosearch Technologies Company Detail

11.8.2 LGC Biosearch Technologies Business Overview

11.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Introduction

11.8.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.8.5 LGC Biosearch Technologies Recent Development

11.9 Nitto Denko Avecia

11.9.1 Nitto Denko Avecia Company Detail

11.9.2 Nitto Denko Avecia Business Overview

11.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Introduction

11.9.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.9.5 Nitto Denko Avecia Recent Development

11.10 Genscript

11.10.1 Genscript Company Detail

11.10.2 Genscript Business Overview

11.10.3 Genscript Oligonucleotide Synthesis Introduction

11.10.4 Genscript Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.10.5 Genscript Recent Development

11.11 Genedesign

11.11.1 Genedesign Company Detail

11.11.2 Genedesign Business Overview

11.11.3 Genedesign Oligonucleotide Synthesis Introduction

11.11.4 Genedesign Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.11.5 Genedesign Recent Development

11.12 TriLink Biotechnologies

11.12.1 TriLink Biotechnologies Company Detail

11.12.2 TriLink Biotechnologies Business Overview

11.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Introduction

11.12.4 TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.12.5 TriLink Biotechnologies Recent Development

11.13 Bio-Synthesis

11.13.1 Bio-Synthesis Company Detail

11.13.2 Bio-Synthesis Business Overview

11.13.3 Bio-Synthesis Oligonucleotide Synthesis Introduction

11.13.4 Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.13.5 Bio-Synthesis Recent Development

11.14 ATDBio

11.14.1 ATDBio Company Detail

11.14.2 ATDBio Business Overview

11.14.3 ATDBio Oligonucleotide Synthesis Introduction

11.14.4 ATDBio Revenue in Oligonucleotide Synthesis Business (2017-2022)

11.14.5 ATDBio Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Key Players of Custom Oligonucleotides

    Table 3. Key Players of Pre-designed Oligonucleotides

    Table 4. Global Oligonucleotide Synthesis Market Size Growth by End User (US$ Million): 2017 VS 2021 VS 2028

    Table 5. Global Oligonucleotide Synthesis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Oligonucleotide Synthesis Market Size by Region (2017-2022) & (US$ Million)

    Table 7. Global Oligonucleotide Synthesis Market Share by Region (2017-2022)

    Table 8. Global Oligonucleotide Synthesis Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 9. Global Oligonucleotide Synthesis Market Share by Region (2023-2028)

    Table 10. Oligonucleotide Synthesis Market Trends

    Table 11. Oligonucleotide Synthesis Market Drivers

    Table 12. Oligonucleotide Synthesis Market Challenges

    Table 13. Oligonucleotide Synthesis Market Restraints

    Table 14. Global Oligonucleotide Synthesis Revenue by Players (2017-2022) & (US$ Million)

    Table 15. Global Oligonucleotide Synthesis Market Share by Players (2017-2022)

    Table 16. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2021)

    Table 17. Ranking of Global Top Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2021

    Table 18. Global 5 Largest Players Market Share by Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2017-2022)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Oligonucleotide Synthesis Product Solution and Service

    Table 21. Date of Enter into Oligonucleotide Synthesis Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million)

    Table 24. Global Oligonucleotide Synthesis Revenue Market Share by Type (2017-2022)

    Table 25. Global Oligonucleotide Synthesis Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 26. Global Oligonucleotide Synthesis Revenue Market Share by Type (2023-2028)

    Table 27. Global Oligonucleotide Synthesis Market Size by End User (2017-2022) & (US$ Million)

    Table 28. Global Oligonucleotide Synthesis Revenue Market Share by End User (2017-2022)

    Table 29. Global Oligonucleotide Synthesis Forecasted Market Size by End User (2023-2028) & (US$ Million)

    Table 30. Global Oligonucleotide Synthesis Revenue Market Share by End User (2023-2028)

    Table 31. North America Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)

    Table 32. North America Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)

    Table 33. Europe Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)

    Table 34. Europe Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)

    Table 35. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2017-2022) & (US$ Million)

    Table 36. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2023-2028) & (US$ Million)

    Table 37. Latin America Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)

    Table 38. Latin America Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)

    Table 39. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)

    Table 40. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)

    Table 41. Integrated DNA Technologies Company Detail

    Table 42. Integrated DNA Technologies Business Overview

    Table 43. Integrated DNA Technologies Oligonucleotide Synthesis Product

    Table 44. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 45. Integrated DNA Technologies Recent Development

    Table 46. Merck Company Detail

    Table 47. Merck Business Overview

    Table 48. Merck Oligonucleotide Synthesis Product

    Table 49. Merck Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 50. Merck Recent Development

    Table 51. Eurofins Genomics Company Detail

    Table 52. Eurofins Genomics Business Overview

    Table 53. Eurofins Genomics Oligonucleotide Synthesis Product

    Table 54. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 55. Eurofins Genomics Recent Development

    Table 56. Thermo Fisher Scientific Company Detail

    Table 57. Thermo Fisher Scientific Business Overview

    Table 58. Thermo Fisher Scientific Oligonucleotide Synthesis Product

    Table 59. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 60. Thermo Fisher Scientific Recent Development

    Table 61. Agilent Technologies Company Detail

    Table 62. Agilent Technologies Business Overview

    Table 63. Agilent Technologies Oligonucleotide Synthesis Product

    Table 64. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 65. Agilent Technologies Recent Development

    Table 66. Eurogentec Company Detail

    Table 67. Eurogentec Business Overview

    Table 68. Eurogentec Oligonucleotide Synthesis Product

    Table 69. Eurogentec Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 70. Eurogentec Recent Development

    Table 71. GE Healthcare Company Detail

    Table 72. GE Healthcare Business Overview

    Table 73. GE Healthcare Oligonucleotide Synthesis Product

    Table 74. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 75. GE Healthcare Recent Development

    Table 76. LGC Biosearch Technologies Company Detail

    Table 77. LGC Biosearch Technologies Business Overview

    Table 78. LGC Biosearch Technologies Oligonucleotide Synthesis Product

    Table 79. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 80. LGC Biosearch Technologies Recent Development

    Table 81. Nitto Denko Avecia Company Detail

    Table 82. Nitto Denko Avecia Business Overview

    Table 83. Nitto Denko Avecia Oligonucleotide Synthesis Product

    Table 84. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 85. Nitto Denko Avecia Recent Development

    Table 86. Genscript Company Detail

    Table 87. Genscript Business Overview

    Table 88. Genscript Oligonucleotide Synthesis Product

    Table 89. Genscript Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 90. Genscript Recent Development

    Table 91. Genedesign Company Detail

    Table 92. Genedesign Business Overview

    Table 93. Genedesign Oligonucleotide SynthesisProduct

    Table 94. Genedesign Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 95. Genedesign Recent Development

    Table 96. TriLink Biotechnologies Company Detail

    Table 97. TriLink Biotechnologies Business Overview

    Table 98. TriLink Biotechnologies Oligonucleotide SynthesisProduct

    Table 99. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 100. TriLink Biotechnologies Recent Development

    Table 101. Bio-Synthesis Company Detail

    Table 102. Bio-Synthesis Business Overview

    Table 103. Bio-Synthesis Oligonucleotide SynthesisProduct

    Table 104. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 105. Bio-Synthesis Recent Development

    Table 106. ATDBio Company Detail

    Table 107. ATDBio Business Overview

    Table 108. ATDBio Oligonucleotide SynthesisProduct

    Table 109. ATDBio Revenue in Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)

    Table 110. ATDBio Recent Development

    Table 111. Research Programs/Design for This Report

    Table 112. Key Data Information from Secondary Sources

    Table 113. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Oligonucleotide Synthesis Market Share by Type: 2021 VS 2028

    Figure 2. Custom Oligonucleotides Features

    Figure 3. Pre-designed Oligonucleotides Features

    Figure 4. Global Oligonucleotide Synthesis Market Share by End User in 2021 & 2028

    Figure 5. Academic Research Institutes Case Studies

    Figure 6. Pharmaceutical and Biotechnology Companies Case Studies

    Figure 7. Diagnostic Laboratories Case Studies

    Figure 8. Others Case Studies

    Figure 9. Oligonucleotide Synthesis Report Years Considered

    Figure 10. Global Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Oligonucleotide Synthesis Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Oligonucleotide Synthesis Market Share by Region: 2021 VS 2028

    Figure 13. Global Oligonucleotide Synthesis Market Share by Players in 2021

    Figure 14. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Synthesis as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2021

    Figure 16. North America Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 17. North America Oligonucleotide Synthesis Market Share by Country (2017-2028)

    Figure 18. United States Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 19. Canada Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Europe Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Oligonucleotide Synthesis Market Share by Country (2017-2028)

    Figure 22. Germany Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 23. France Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 24. U.K. Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 25. Italy Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. Russia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. Nordic Countries Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Asia-Pacific Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Asia-Pacific Oligonucleotide Synthesis Market Share by Region (2017-2028)

    Figure 30. China Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Japan Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. South Korea Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 33. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 34. India Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 35. Australia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Latin America Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Latin America Oligonucleotide Synthesis Market Share by Country (2017-2028)

    Figure 38. Mexico Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Brazil Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Middle East & Africa Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Middle East & Africa Oligonucleotide Synthesis Market Share by Country (2017-2028)

    Figure 42. Turkey Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 43. Saudi Arabia Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 44. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 45. Merck Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 46. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 48. Agilent Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 49. Eurogentec Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 50. GE Healthcare Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 51. LGC Biosearch Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 52. Nitto Denko Avecia Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 53. Genscript Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 54. Genedesign Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 55. TriLink Biotechnologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 56. Bio-Synthesis Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 57. ATDBio Revenue Growth Rate in Oligonucleotide Synthesis Business (2017-2022)

    Figure 58. Bottom-up and Top-down Approaches for This Report

    Figure 59. Data Triangulation

    Figure 60. Key Executives Interviewed